Generic Yeztugo Availability
Last updated on Jul 9, 2025.
Yeztugo is a brand name of lenacapavir, approved by the FDA in the following formulation(s):
YEZTUGO (lenacapavir sodium - solution;subcutaneous)
-
Manufacturer: GILEAD SCIENCES INC
Approval date: June 18, 2025
Strength(s): EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) [RLD]
YEZTUGO (lenacapavir sodium - tablet;oral)
-
Manufacturer: GILEAD SCIENCES INC
Approval date: June 18, 2025
Strength(s): EQ 300MG BASE [RLD]
Is there a generic version of Yeztugo available?
No. There is currently no therapeutically equivalent version of Yeztugo available in the United States.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Yeztugo. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Yeztugo (lenacapavir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Related/similar drugs
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Apretude
Apretude is used to prevent HIV (HIV PrEP) in adults and adolescents weighing at least 77 pounds ...
Sunlenca
Sunlenca (lenacapavir) is used for the treatment of HIV-1 infection in heavily ...
Vocabria
Vocabria (cabotegravir) is used in the treatment of HIV-1 infection in adults. Includes Vocabria ...
AccessPak for HIV PEP Basic
AccessPak for HIV PEP Basic is used for HIV Infection, nonoccupational exposure, occupational ...
Cabotegravir
Cabotegravir is an antiviral medication used for the prevention and treatment of HIV. Brand names ...
Emtricitabine/tenofovir disoproxil
Emtricitabine/tenofovir disoproxil (brand name Truvada) is a combination antiviral tablet that may ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
